SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAGLIATI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.962
AS - Asia 4.992
EU - Europa 2.666
SA - Sud America 712
AF - Africa 120
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.462
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.759
SG - Singapore 1.864
CN - Cina 1.337
DE - Germania 600
VN - Vietnam 591
BR - Brasile 554
UA - Ucraina 432
IT - Italia 395
HK - Hong Kong 364
GB - Regno Unito 302
TR - Turchia 264
FI - Finlandia 239
FR - Francia 163
RU - Federazione Russa 134
SE - Svezia 133
BD - Bangladesh 121
JP - Giappone 119
IN - India 95
CA - Canada 93
PL - Polonia 84
MX - Messico 70
AR - Argentina 62
ID - Indonesia 42
ZA - Sudafrica 42
IQ - Iraq 37
NL - Olanda 31
BE - Belgio 30
PK - Pakistan 29
ES - Italia 28
EC - Ecuador 22
UZ - Uzbekistan 19
AT - Austria 18
LT - Lituania 18
VE - Venezuela 18
CO - Colombia 16
CL - Cile 15
EG - Egitto 15
DZ - Algeria 13
PH - Filippine 13
SA - Arabia Saudita 13
JM - Giamaica 12
JO - Giordania 11
KE - Kenya 11
IE - Irlanda 9
MA - Marocco 9
TN - Tunisia 9
CH - Svizzera 8
LB - Libano 8
TW - Taiwan 8
UY - Uruguay 8
AL - Albania 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
IR - Iran 6
NP - Nepal 6
PY - Paraguay 6
AU - Australia 5
AZ - Azerbaigian 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AM - Armenia 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
LV - Lettonia 3
MD - Moldavia 3
MY - Malesia 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
CY - Cipro 2
DK - Danimarca 2
GA - Gabon 2
HN - Honduras 2
KG - Kirghizistan 2
ML - Mali 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
Totale 18.442
Salva come PNG Salva come JPEG
Città #
Ashburn 1.457
Singapore 1.265
Woodbridge 890
Fairfield 716
San Jose 696
Chandler 565
Houston 524
Jacksonville 492
Beijing 440
Santa Clara 406
Ann Arbor 380
Hong Kong 350
Seattle 300
Wilmington 266
Cambridge 215
Ho Chi Minh City 190
Los Angeles 178
Addison 150
New York 149
Munich 145
Hanoi 138
Nanjing 137
Izmir 134
Dallas 128
Ferrara 120
Tokyo 118
Princeton 99
Lauterbourg 91
Helsinki 88
Boardman 86
Shanghai 80
Milan 78
Warsaw 78
Dearborn 67
São Paulo 64
San Diego 60
Turku 54
Orem 51
Mexico City 48
Shenyang 44
Council Bluffs 42
Bremen 41
Buffalo 41
Tianjin 39
Brooklyn 37
Nanchang 36
London 34
Da Nang 32
Denver 32
Montreal 32
Atlanta 31
Changsha 31
Chicago 30
Hebei 29
Johannesburg 29
Brussels 28
Chennai 28
Haiphong 28
Washington 27
Frankfurt am Main 26
Hefei 25
Jinan 25
Toronto 25
Jakarta 24
Manchester 24
Mountain View 24
Nuremberg 22
Jiaxing 21
Kunming 20
Tappahannock 19
Amsterdam 18
Boston 18
Guangzhou 18
Phoenix 18
Baghdad 17
Poplar 17
Rome 17
San Francisco 17
Hải Dương 16
Moscow 16
Stockholm 16
Tashkent 16
Ankara 15
Falls Church 15
Brasília 14
Norwalk 14
Biên Hòa 13
City of London 13
Falkenstein 13
Rio de Janeiro 13
Verona 13
Belo Horizonte 12
Redwood City 12
Amman 11
Auburn Hills 11
Charlotte 11
Leawood 11
Bologna 10
Indiana 10
Mumbai 10
Totale 12.844
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 433
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 286
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 279
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 276
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 265
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 264
Igf-I influences everolimus activity in medullary thyroid carcinoma 262
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 259
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 254
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 252
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 249
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 243
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 239
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 237
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 233
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 233
Functional characterization of a new deletion in CDKN1B 5'-UTR region 230
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 226
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 226
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 226
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 220
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 218
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 217
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 213
Growth hormone induces chemoresistance in breast cancer cells 213
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 213
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 212
Growth hormone excess promotes breast cancer chemoresistance 211
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 210
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 210
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 209
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 202
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 202
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 202
miR-15a and miR-16-1 down-regulation in pituitary adenomas 201
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 201
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 200
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 199
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 199
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 196
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 191
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 187
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 186
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 186
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 182
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 182
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 181
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 181
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 180
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 180
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 179
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 178
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 177
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 177
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 177
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 172
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 172
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 171
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 170
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 166
Effects of pasireotide on bronchial carcinoids in primary culture 165
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 164
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 164
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 164
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 161
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 160
Real-time PCR is useful to detect menin gene deletions 158
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 157
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 157
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 155
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 154
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 153
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 152
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 152
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 152
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 150
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 149
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 144
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 144
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 143
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 143
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 142
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 136
A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia 132
α-Pinene, a Main Component of Pinus Essential Oils, Enhances the Expression of Insulin-Sensitive Glucose Transporter Type 4 in Murine Skeletal Muscle Cells 121
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 119
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 119
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 118
Targeting PKC in human pancreatic neuroendocrine tumor cells 117
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 117
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 114
Validation of a murine model to study deregulated pituitary microRNA 113
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 113
miR-26a targets PRKCD in ACTH pituitary adenoma 109
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  109
null 106
null 92
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 81
Role of piuitary tumour transforming gene 1 in medullary thyroid carcinoma 80
Totale 18.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 0 65
2021/20221.041 37 101 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024908 60 66 28 19 59 105 23 373 19 13 8 135
2024/20252.397 52 46 192 66 312 328 67 70 343 243 365 313
2025/20267.117 716 302 557 785 1.199 472 967 352 683 737 250 97
Totale 18.577